Pancreatic carcinoma cell lines stably expressing the CEACAM6 shRNA and yCDglyTK gene were then established and anti-tumor efficacy of the recombinant plasmid was evaluated in vitro. Here, CEACAM6 is linked to exocrine pancreatic carcinoma.